PIERIS PHARMACEUTICALS INC (PIRS) Stock Analyst Earnings Estimates
NASDAQ:PIRS - Nasdaq - US7207952026 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 31.418M 7.14% | 25.902M -17.56% | 42.81M 65.28% | 6.758M -84.21% | -100.00% | 17.85M | 193.39M 983.42% | 213.49M 10.39% | 235.52M 10.32% | ||
| EBITDA YoY % growth | -49.372M -56.19% | -40.704M 17.56% | -13.94M 65.75% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -51.831M -52.80% | -43.474M 16.12% | -15.844M 63.56% | -22.282M -40.63% | -27.151M -21.85% | -28.647M -5.51% | -42.33M -47.77% | 148.1M 449.87% | 170.85M 15.36% | 194.41M 13.79% | |
| Operating Margin | -164.97% | -167.84% | -37.01% | -329.71% | N/A | N/A | -237.14% | 76.58% | 80.03% | 82.55% | |
| EPS YoY % growth | -55.37 -1.79% | -36.00 34.99% | N/A 99.01% | -0.20 42.86% | -0.30 -45.00% | -0.32 -6.90% | N/A | N/A | N/A | N/A |
All data in USD
| Q4 / 24 | |
|---|---|
| EPS Q2Q % growth | -0.06 50.00% |
| Revenue Q2Q % growth | 1.09M -16.09% |
| EBITDA Q2Q % growth | N/A |
| EBIT Q2Q % growth | N/A |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q1 2024 Q2Q % growth | 99.58% | -0.06 | % | |
| Q4 2023 Q2Q % growth | 98.61% | -0.12 | % | |
| Q3 2023 Q2Q % growth | 3.20 130.77% | -8.98 | 12.18 | 135.65% |
| Q2 2023 Q2Q % growth | 4.00 135.71% | -13.06 | 17.06 | 130.64% |
| Q1 2023 Q2Q % growth | -14.40 -157.14% | -11.42 | -2.98 | -26.05% |
| Q4 2022 Q2Q % growth | -8.80 16.76% | -18.77 | 9.97 | 53.11% |
| Q3 2022 Q2Q % growth | -10.40 45.83% | -13.06 | 2.66 | 20.34% |
| Q2 2022 Q2Q % growth | -11.20 44.00% | -8.98 | -2.22 | -24.78% |
| Q1 2022 Q2Q % growth | -5.60 | -9.38 | 3.78 | 40.32% |
| Q4 2021 Q2Q % growth | -10.57 49.17% | -24.48 | 13.91 | 56.81% |
| Q3 2021 Q2Q % growth | -19.20 7.69% | -19.86 | 0.66 | 3.30% |
| Q2 2021 Q2Q % growth | -20.00 -177.78% | -21.62 | 1.62 | 7.51% |
| Q1 2021 Q2Q % growth | -5.60 | -13.87 | 8.27 | 59.63% |
| Q4 2020 Q2Q % growth | -20.80 -333.33% | -19.31 | -1.49 | -7.70% |
| Q3 2020 Q2Q % growth | -20.80 -420.00% | -10.62 | -10.18 | -95.78% |
| Q2 2020 Q2Q % growth | -7.20 62.50% | -14.00 | 6.80 | 48.58% |
| Q1 2020 Q2Q % growth | -5.60 65.00% | -13.55 | 7.95 | 58.66% |
| Q4 2019 Q2Q % growth | -4.80 | -22.68 | 17.88 | 78.84% |
| Q3 2019 Q2Q % growth | -4.00 | -18.74 | 14.74 | 78.65% |
| Q2 2019 Q2Q % growth | -19.20 | -16.40 | -2.80 | -17.06% |
| Q1 2019 Q2Q % growth | -16.00 | -16.34 | 0.34 | 2.08% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q1 2024 Q2Q % growth | 53K -97.26% | 2.289M | -2.236M | -97.68% |
| Q4 2023 Q2Q % growth | 1.299M -77.78% | 2.289M | -990K | -43.25% |
| Q3 2023 Q2Q % growth | 19.52M 263.50% | 7.899M | 11.621M | 147.12% |
| Q2 2023 Q2Q % growth | 20.055M 442.32% | 4.099M | 15.956M | 389.27% |
| Q1 2023 Q2Q % growth | 1.936M -82.38% | 6.636M | -4.7M | -70.83% |
| Q4 2022 Q2Q % growth | 5.846M -30.76% | 6.641M | -795K | -11.97% |
| Q3 2022 Q2Q % growth | 5.37M 32.36% | 2.301M | 3.069M | 133.38% |
| Q2 2022 Q2Q % growth | 3.698M 12.57% | 10.68M | -6.982M | -65.37% |
| Q1 2022 Q2Q % growth | 10.988M -29.71% | 11.53M | -542K | -4.70% |
| Q4 2021 Q2Q % growth | 8.443M 349.81% | 2.503M | 5.94M | 237.32% |
| Q3 2021 Q2Q % growth | 4.057M 38.04% | 5.423M | -1.366M | -25.19% |
| Q2 2021 Q2Q % growth | 3.285M -70.79% | 2.117M | 1.168M | 55.17% |
| Q1 2021 Q2Q % growth | 15.633M 17.89% | 6.596M | 9.037M | 137.01% |
| Q4 2020 Q2Q % growth | 1.877M -89.13% | 3.893M | -2.016M | -51.79% |
| Q3 2020 Q2Q % growth | 2.939M -80.58% | 9.99M | -7.051M | -70.58% |
| Q2 2020 Q2Q % growth | 11.246M 110.92% | 7.918M | 3.328M | 42.03% |
| Q1 2020 Q2Q % growth | 13.261M 55.19% | 9.017M | 4.244M | 47.07% |
| Q4 2019 Q2Q % growth | 17.27M | 4.921M | 12.349M | 250.94% |
| Q3 2019 Q2Q % growth | 15.132M | 6.545M | 8.587M | 131.20% |
| Q2 2019 Q2Q % growth | 5.332M | 8.365M | -3.033M | -36.26% |
| Q1 2019 Q2Q % growth | 8.545M | 7.162M | 1.383M | 19.31% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | 0% | 0% | 0% |
| Revenue | 0% | 0% | 0% | 0% |